Published in Int J Cancer on May 05, 1999
The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer (2009) 9.01
Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy. Obstet Gynecol (2011) 1.68
Risk factors for epithelial ovarian cancer by histologic subtype. Am J Epidemiol (2009) 1.62
Perineal powder use and risk of ovarian cancer. J Natl Cancer Inst (2014) 1.58
Markers of inflammation and risk of ovarian cancer in Los Angeles County. Int J Cancer (2009) 1.52
The epidemiology of endometrial and ovarian cancer. Hematol Oncol Clin North Am (2011) 1.34
Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls. Cancer Prev Res (Phila) (2013) 1.17
Epidemiologic perspective on immune-surveillance in cancer. Curr Opin Immunol (2011) 1.16
Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev (2010) 1.15
Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.02
Molecular pathogenesis of endometrial and ovarian cancer. Cancer Biomark (2010) 0.95
Perineal talc use and ovarian cancer: a critical review. Eur J Cancer Prev (2008) 0.91
Perineal use of talcum powder and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev (2010) 0.86
Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES). Cancer Epidemiol Biomarkers Prev (2016) 0.84
The Association Between Talc Use and Ovarian Cancer: A Retrospective Case-Control Study in Two US States. Epidemiology (2016) 0.84
Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications. Transl Cancer Res (2015) 0.80
Early preinvasive lesions in ovarian cancer. Biomed Res Int (2014) 0.79
Body Powder and Ovarian Cancer Risk-What Is the Role of Recall Bias? Cancer Epidemiol Biomarkers Prev (2016) 0.75
Douching, Talc Use, and Risk of Ovarian Cancer. Epidemiology (2016) 0.75
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med (1991) 19.46
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States medicare population. J Bone Joint Surg Am (2001) 7.67
The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. Am J Public Health (1992) 6.97
A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med (1994) 5.98
Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med (1994) 5.37
The framing effect of relative and absolute risk. J Gen Intern Med (1993) 4.87
Prognosis of cancers associated with venous thromboembolism. N Engl J Med (2000) 4.51
Ethics of a prostate cancer screening trial. Lancet (1994) 4.21
Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med (1999) 4.11
Midline episiotomy and anal incontinence: retrospective cohort study. BMJ (2000) 3.83
Statewide study of diagnostic agreement in breast pathology. J Natl Cancer Inst (1998) 3.77
Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev (2001) 3.40
Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol (1996) 3.40
Heterogeneity of hip fracture: age, race, sex, and geographic patterns of femoral neck and trochanteric fractures among the US elderly. Am J Epidemiol (1996) 3.16
Pregnancy termination in relation to risk of breast cancer. JAMA (1996) 3.04
Changes in prostate cancer incidence and treatment in USA. Lancet (1994) 3.01
Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheum (1997) 2.93
Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol (1983) 2.90
Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst (1983) 2.57
Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer (2003) 2.43
Ovarian sex cord tumor with annular tubules: review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix. Cancer (1982) 2.42
An assessment of prostatectomy for benign urinary tract obstruction. Geographic variations and the evaluation of medical care outcomes. JAMA (1988) 2.42
Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. Am J Clin Pathol (1983) 2.33
Social and economic factors in the choice of lung cancer treatment. A population-based study in two rural states. N Engl J Med (1988) 2.33
Hip fracture incidence and mortality in New England. Epidemiology (1991) 2.32
Smoking and estrogen-related disease. Am J Epidemiol (1984) 2.31
Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect (1998) 2.22
Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet (1989) 2.20
The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark. Aliment Pharmacol Ther (2015) 2.16
Jewish religion and risk of breast cancer. Lancet (1996) 2.14
A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N Engl J Med (1990) 2.13
Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer (1999) 2.04
Telepathology diagnosis by means of digital still images: an international validation study. Hum Pathol (1996) 2.03
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer (1999) 1.98
Electric blanket or mattress cover use and breast cancer incidence in women 50-79 years of age. Epidemiology (2001) 1.96
The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med (1994) 1.96
Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost (2009) 1.95
Antioxidant vitamins, cancer, and cardiovascular disease. N Engl J Med (1996) 1.90
Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res (1993) 1.89
Overcoming potential pitfalls in the use of Medicare data for epidemiologic research. Am J Public Health (1990) 1.88
Treatment and survival among elderly Americans with hip fractures: a population-based study. Am J Public Health (1994) 1.83
Effect of intravenous streptokinase on early mortality in patients with suspected acute myocardial infarction. A meta-analysis by anatomic location of infarction . Ann Intern Med (1990) 1.82
Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol (2001) 1.80
Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med (1994) 1.77
Postpartum sexual functioning and its relationship to perineal trauma: a retrospective cohort study of primiparous women. Am J Obstet Gynecol (2001) 1.75
Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst (1999) 1.73
Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst (1983) 1.71
Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst (1998) 1.64
Body size and risk of breast cancer. Am J Epidemiol (1997) 1.63
Predicting risk of complications with gynecologic laparoscopic surgery. Obstet Gynecol (1998) 1.62
Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control (2000) 1.61
The epidemiology of sarcomas of the uterus. J Natl Cancer Inst (1986) 1.59
Over-the-counter analgesics and risk of ovarian cancer. Lancet (1998) 1.59
Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci U S A (1992) 1.58
Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med (1984) 1.58
Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation. Aliment Pharmacol Ther (2011) 1.58
Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control (2000) 1.56
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer (2009) 1.54
Oral-contraceptive use and risk of hip fracture: a case-control study. Lancet (1999) 1.53
The influence of lactose consumption on the association of oral contraceptive use and ovarian cancer risk. Am J Epidemiol (1991) 1.52
Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas. Gynecol Oncol (1993) 1.52
Occupational exposure to 60-hertz magnetic fields and risk of breast cancer in women. Epidemiology (1996) 1.51
Postmenopausal squamous atypia: a spectrum including "pseudo-koilocytosis". Mod Pathol (1995) 1.50
Fracture risk in the U.S. Medicare population. J Clin Epidemiol (1999) 1.49
Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group. BMJ (1998) 1.48
Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum. Hum Pathol (2000) 1.48
Multilocular peritoneal inclusion cysts (so-called cystic mesotheliomas). Cancer (1989) 1.46
Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis. Breast Cancer Res Treat (2011) 1.45
The influence of gestational age and smoking habits on the risk of subsequent preterm deliveries. N Engl J Med (1999) 1.44
Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol (2000) 1.44
Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer (1999) 1.44
Adult onset of major depressive disorder in relation to early life violent victimisation: a case-control study. Lancet (2001) 1.44
Cancer staging may have different meanings in academic and community hospitals. J Clin Epidemiol (1991) 1.43
Small sac size in the first trimester: a predictor of poor fetal outcome. Radiology (1991) 1.42
Use of oral contraceptives and endometrial cancer risk (Sweden). Cancer Causes Control (1999) 1.42
KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers. Br J Cancer (2013) 1.41
Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. The Polyp Prevention Study Group. Gastroenterology (1998) 1.40
The utility of patient age in evaluating prostate cancer. Am J Clin Pathol (1997) 1.40
Left-handedness in relation to breast cancer risk in postmenopausal women. Epidemiology (2000) 1.40
Menstrual factors in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev (1998) 1.38
Menstrual and reproductive factors in relation to ovarian cancer risk. Br J Cancer (2001) 1.37
Cancer risk and mortality in users of calcium channel blockers. A cohort study. Cancer (2000) 1.36
Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol (1995) 1.35
Long-term morbidity following jejunoileal bypass. The continuing potential need for surgical reversal. Arch Surg (1995) 1.35
Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol (2000) 1.35
A randomized controlled trial of low carbohydrate and low fat/high fiber diets for weight loss. Am J Public Health (1986) 1.33
Cigarette smoking and Parkinson's disease. Neurology (1986) 1.33